← Alle mensen

CR

C Robert

11 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology · 2025-10
Cutaan melanoom: ESMO 2025 richtlijn update
Annals of oncology : official journal of the European Society for Medical Oncology · 2025-01
Pembrolizumab versus ipilimumab bij gevorderd melanoom: KEYNOTE-006 tienjaars
Annals of oncology : official journal of the European Society for Medical Oncology · 2024-12
Biomarkers bij atezolizumab-vemurafenib-cobimetinib bij BRAF-melanoom: IMspire150 analyse
Annals of oncology : official journal of the European Society for Medical Oncology · 2022-05
Activiteit van ipilimumab of BRAF/MEK na pembrolizumab bij melanoom
Annals of oncology : official journal of the European Society for Medical Oncology · 2022-02
Locoregionaal melanoom: ESMO consensusaanbevelingen
Annals of oncology : official journal of the European Society for Medical Oncology · 2020-11
Gemetastaseerd melanoom: ESMO consensusaanbevelingen
Annals of oncology : official journal of the European Society for Medical Oncology · 2020-11
Vijfjaarsoverleving met pembrolizumab bij gevorderd melanoom: KEYNOTE-001 update
Annals of oncology : official journal of the European Society for Medical Oncology · 1 april 2019
Vemurafenib bij BRAF V600-gemuteerd melanoom: definitieve totale overlevingsresultaten BRIM-3
Annals of oncology : official journal of the European Society for Medical Oncology · 1 oktober 2017
Dabrafenib plus trametinib versus dabrafenib alleen bij BRAF V600-gemuteerd melanoom: langetermijnresultaten COMBI-d
Annals of oncology : official journal of the European Society for Medical Oncology · 1 juli 2017
Effect van nivolumab op kwaliteit van leven bij niet eerder behandeld gevorderd melanoom: CheckMate 066
Annals of oncology : official journal of the European Society for Medical Oncology · 2016-10